RA CAPITAL MANAGEMENT, L.P. Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$1.7T
Holdings
32
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (32 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ASNDASCENDIS PHARMA A S | 4,132,442 | $398.0B | 23.72% | |
| 2 | WVEWAVE LIFE SCIENCES LTD | 7,775,207 | $159.6B | 9.51% | |
| 3 | —SYNTHORX INC | 9,724,598 | $158.2B | 9.43% | |
| 4 | —RA PHARMACEUTICALS INC | 4,858,260 | $114.9B | 6.85% | |
| 5 | —ZOGENIX INC | 2,260,751 | $90.5B | 5.39% | |
| 6 | —EIDOS THERAPEUTICS INC | 2,162,671 | $77.8B | 4.63% | |
| 7 | RYTMRHYTHM PHARMACEUTICALS INC | 3,422,312 | $73.9B | 4.40% | |
| 8 | —SATSUMA PHARMACEUTICALS INC | 4,681,858 | $70.3B | 4.19% | |
| 9 | ORTXUSDORCHARD THERAPEUTICS PLC | 5,224,475 | $62.1B | 3.70% | |
| 10 | SLDBSOLID BIOSCIENCES INC | 4,571,164 | $47.3B | 2.82% | |
| 11 | —RETROPHIN INC | 3,987,560 | $46.2B | 2.75% | |
| 12 | —PREVAIL THERAPEUTICS INC | 3,363,605 | $41.3B | 2.46% | |
| 13 | TGTXTG THERAPEUTICS INC | 6,880,323 | $38.6B | 2.30% | |
| 14 | ARVNARVINAS INC | 1,663,512 | $35.8B | 2.14% | |
| 15 | —DICERNA PHARMACEUTICALS INC | 2,456,669 | $35.3B | 2.10% | |
| 16 | —MYOVANT SCIENCES LTD | 6,166,875 | $32.1B | 1.91% | |
| 17 | CRNXCRINETICS PHARMACEUTICALS INC | 1,875,209 | $28.2B | 1.68% | |
| 18 | STOKSTOKE THERAPEUTICS INC | 1,119,963 | $24.1B | 1.43% | |
| 19 | SCPHSCPHARMACEUTICALS INC | 3,247,005 | $19.1B | 1.14% | |
| 20 | KALAKALA PHARMACEUTICALS INC | 4,537,478 | $17.3B | 1.03% | |
| 21 | DTILPRECISION BIOSCIENCES INC | 1,842,366 | $15.5B | 0.92% | |
| 22 | KODKODIAK SCIENCES INC | 1,025,165 | $14.7B | 0.88% | |
| 23 | ALECALECTOR INC | 1,000,000 | $14.4B | 0.86% | |
| 24 | AXSMAXSOME THERAPEUTICS INC | 664,385 | $13.4B | 0.80% | |
| 25 | —PORTOLA PHARMACEUTICALS INC | 429,399 | $11.5B | 0.69% | |
| 26 | DVAXDYNAVAX TECHNOLOGIES CORP | 2,365,912 | $8.5B | 0.50% | |
| 27 | 1K0IGM BIOSCIENCES INC | 466,368 | $8.3B | 0.49% | |
| 28 | ASNSUSDX4 PHARMACEUTICALS INC | 478,107 | $6.1B | 0.36% | |
| 29 | —ODONATE THERAPEUTICS INC | 200,000 | $5.2B | 0.31% | |
| 30 | CMRXEURCHIMERIX INC | 1,782,202 | $4.2B | 0.25% | |
| 31 | EPIEURESSA PHARMA INC | 1,000,000 | $3.4B | 0.20% | |
| 32 | SENS1GBPSENSEONICS HLDGS INC | 2,727,273 | $2.7B | 0.16% |